BAM
IMMU

Bullseye Asset Management’s Immunomedics Inc IMMU Stock Holding History

Bullseye Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-85,319
Closed -$7.25M – 111
2020
Q3 		$7.25M Sell
85,319
-68
-0.1% -$3.44K 3.3% 1
2020
Q2 		$3.03M Buy
85,387
+20,548
+32% +$601K 1.62% 21
2020
Q1 		$874K Sell
64,839
-542
-0.8% -$9.12K 1.04% 36
2019
Q4 		$1.38M Buy
+65,381
New +$1.15M 1.34% 32

Bullseye Asset Management's IMMU Position: Q4 2020 in Review

Bullseye Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 85,319 shares — an estimated $7.25M sold.

Bullseye Asset Management first reported a position in IMMU in Q4 2019 and held it in 4 quarters. The position peaked at $7.25M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Bullseye Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Bullseye Asset Management sold 85,319 Immunomedics Inc shares in Q4 2020, an estimated $7.25M.
  • Bullseye Asset Management first reported a position in Immunomedics Inc in Q4 2019 and held it in 4 quarters.
  • Bullseye Asset Management's Immunomedics Inc position peaked at $7.25M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Bullseye Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.